
Media
Media
Our latest press releases
Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma
Regulatory press release
01/09/2023
Hansa Biopharma: Increase of the number of votes
Regulatory press release
31/07/2023
Hansa Biopharma half year report 2023
Regulatory press release
20/07/2023
First patient treated with imlifidase in an investigator-initiated Phase 2 study in ANCA-associated vasculitis
19/07/2023
Media
News and insights
Building a better knowledge of anti-GBM disease
10/05/2023
Acknowledging Disparities Between Sexes in Kidney Transplantation this World Kidney Day
09/03/2023
Pride and commitment: how we shape Hansa into a truly great place to work
30/09/2022
Understanding the individual unmet needs of highly sensitized patients awaiting kidney transplant
10/03/2022
Meetings of interest
Impactful interaction with the scientific and medical community
At Hansa, we are focused on the bigger picture and want help rare disease patients live long and healthy lives. We do this also by constant engagement with the scientific and healthcare communities. We use this opportunity to not only raise awareness about the unmet needs of the patients, but also to help advance the understanding in these complex fields. Meetings of interest